On this page
Ibrutinib
Active ingredient 3 prescription 2 with labelling
Overview
Source: NDC DirectoryIngredient name
IBRUTINIB
Base moiety
IBRUTINIB
RxNorm CUI
UNII
1X70OSD4VX
Medication products
14
Brand names
1
Dosage forms
5
FAERS reports
80,310 · not a risk measure
- Ibrutinib Tablet, Film Coated
- Ibrutinib Powder
- Ibrutinib Capsule
- IBRUTINIB Ibrutinib · Tablet
- Ibrutinib (Form S4) Powder
- Ibrutinib (Form-A) Powder
- Ibrutinib (Form-C) Powder
- Ibrutinib (Form-M5) Powder
- Ibrutinib HFCC Powder
- Ibrutinib(Amorphous) Powder
- Ibutinib Powder
- Imbruvica Ibrutinib · Suspension
- Imbruvica Ibrutinib · Capsule
- Imbruvica Ibrutinib · Tablet, Film Coated
Entries without a link are products listed by the FDA that carry no approval record, therapeutic equivalence rating or official labelling, so they have no detail page. Their facts are shown inline.
By dosage form
| Dosage form | Products | Examples |
|---|---|---|
| Powder | 8 | Ibrutinib, Ibrutinib (Form S4), Ibrutinib (Form-A), Ibrutinib (Form-C) … |
| TABLET, Film Coated | 2 | Ibrutinib, Imbruvica |
| Capsule | 2 | Ibrutinib, Imbruvica |
| Tablet | 1 | IBRUTINIB |
| Suspension | 1 | Imbruvica |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Ingredient name, strengths, products, labelers, packages |
| DailyMed RxNorm mappings | NLM | RxNorm concept identifier (RxCUI) |
| FAERS | FDA | Adverse event report totals |